2026年10月21日，复锐医疗科技(01696)公告披露，于当日通过香港联交所场内回购15万股普通股，占该公司于回购前已发行股本的约0.032%。本次回购的每股价格区间介乎每股港币1.825元至1.90元，合计涉资约28.05万港元。
回购完成后，公司已发行股本由467,894,692股减少至467,744,692股，库藏股数量则增至598,400股，整体股本总数保持468,343,092股不变。该次股份回购依据2026年6月24日获得股东通过的一般授权进行，授权剩余额度为46,834,309股。公司强调已遵守香港联合交易所有限公司证券上市规则及其他适用法律法规。公告由公司秘书方前厉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.